Foghorn Therapeutics Ownership | Who Owns Foghorn Therapeutics?

Overview Forecast RevenueFinancials Chart

Foghorn Therapeutics Ownership Summary

Foghorn Therapeutics is owned by 63.89% institutional investors, 18.98% insiders, and 17.13% retail investors. Flagship pioneering is the largest institutional shareholder, holding 29.87% of FHTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.76% of its assets in Foghorn Therapeutics shares.

FHTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Foghorn Therapeutics	63.89%	18.98%	17.13%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Flagship pioneering	12.67M	29.87%	$72.88M
Fmr	6.38M	15.04%	$36.70M
Bvf inc/il	5.30M	12.50%	$30.49M
Deerfield management company, l.p. (series c)	2.52M	5.94%	$14.48M
Raymond james & associates	2.34M	5.51%	$13.45M
Euclidean capital	1.57M	3.71%	$9.05M
Blackrock	1.55M	3.64%	$8.89M
Vanguard group	1.06M	2.50%	$6.09M
Artal group	720.72K	1.70%	$4.14M
Geode capital management	531.11K	1.25%	$3.05M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Flagship pioneering	12.67M	8.64%	$72.88M
Birchview capital, lp	320.93K	1.71%	$1.85M
Euclidean capital	1.57M	1.14%	$9.05M
Bvf inc/il	5.30M	0.85%	$30.49M
Deerfield management company, l.p. (series c)	2.52M	0.24%	$14.48M
Sio capital management	121.67K	0.19%	$699.61K
Alphabet	500.90K	0.15%	$2.88M
Artal group	720.72K	0.11%	$4.14M
Alta wealth advisors	30.03K	0.09%	$172.68K
Rockwood wealth management	107.33K	0.08%	$617.14K

Top Buyers

Holder	Shares	% Assets	Change
Bvf inc/il	5.30M	0.85%	5.30M
Fmr	6.38M	0.00%	3.69M
Deerfield management company, l.p. (series c)	2.52M	0.24%	2.52M
Blackrock	1.55M	0.00%	230.70K
Raymond james & associates	2.34M	0.01%	107.97K

Top Sellers

Holder	Shares	% Assets	Change
Driehaus capital management	-	-	-568.47K
Perceptive advisors	-	-	-544.00K
Colony group	-	-	-215.69K
Invesco	-	-	-56.04K
Vanguard group	1.06M	0.00%	-43.01K

New Positions

Holder	Shares	% Assets	Change	Value
Bvf inc/il	5.30M	0.85%	5.30M	$30.49M
Deerfield management company, l.p. (series c)	2.52M	0.24%	2.52M	$14.48M
Bridgeway capital management	57.50K	0.01%	57.50K	$330.63K
Wellington management group llp	43.79K	-	43.79K	$251.79K
Dafna capital management	41.85K	0.06%	41.85K	$240.64K

Sold Out

Holder	Change
Zurcher kantonalbank (zurich cantonalbank)	-2.00
Nelson, van denburg & campbell wealth management group	-3.00
Group one trading	-151.00
Visionpoint advisory group	-210.00
Capital analysts	-547.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	80	9.59%	39,996,016	1.40%	63	0.74%	41	7.89%	19	18.75%
Jun 30, 2024	73	5.80%	39,443,565	49.07%	92	2.37%	38	35.71%	16	-11.11%
Mar 31, 2024	69	16.95%	26,459,810	1.01%	62	1.61%	28	16.67%	18	5.88%
Dec 31, 2023	59	-3.28%	26,194,106	-2.71%	62	1.50%	24	26.32%	17	-10.53%
Sep 30, 2023	61	1.67%	26,924,937	0.60%	64	1.57%	19	-24.00%	19	26.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	2.63M	4.76%	14.36K
Fidelity Growth Compy Commingled Pl O	2.62M	4.73%	-
Fidelity Growth Company Fund	1.90M	3.44%	-4.04K
Vanguard Total Stock Mkt Idx Inv	962.18K	1.73%	-
Fidelity Select Biotechnology	751.94K	1.36%	-155.50K
iShares Russell 2000 ETF	618.26K	1.11%	-1.39K
Fidelity Growth Company K6	598.20K	1.08%	-10.32K
Vanguard Institutional Extnd Mkt Idx Tr	518.51K	0.93%	-1.08K
Fidelity Series Growth Company	445.41K	0.81%	-
Fidelity Small Cap Index	262.88K	0.48%	-2.86K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 23, 2024	Costa Carlos	Chief People Officer	Sell	$8.72K
Sep 20, 2024	Costa Carlos	Chief People Officer	Sell	$358.99K
Sep 18, 2024	Costa Carlos	Chief People Officer	Sell	$116.32K
Sep 16, 2024	Costa Carlos	Chief People Officer	Sell	$4.00K
Sep 17, 2024	Costa Carlos	Chief People Officer	Sell	$103.13K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	6
2024 Q2	2	-
2024 Q1	-	1
2023 Q4	-	-
2023 Q3	-	1

FHTX Ownership FAQ

Who Owns Foghorn Therapeutics?

Foghorn Therapeutics shareholders are primarily institutional investors at 63.89%, followed by 18.98% insiders and 17.13% retail investors. The average institutional ownership in Foghorn Therapeutics's industry, Biotech Stocks , is 47.04%, which Foghorn Therapeutics exceeds.

Who owns the most shares of Foghorn Therapeutics?

Foghorn Therapeutics’s largest shareholders are Flagship pioneering (12.67M shares, 29.87%), Fmr (6.38M shares, 15.04%), and Bvf inc/il (5.3M shares, 12.50%). Together, they hold 57.41% of Foghorn Therapeutics’s total shares outstanding.

Does Blackrock own Foghorn Therapeutics?

Yes, BlackRock owns 3.64% of Foghorn Therapeutics, totaling 1.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.89M$. In the last quarter, BlackRock increased its holdings by 230.7K shares, a 17.54% change.

Who is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.64% of its assets in 12.67M Foghorn Therapeutics shares, valued at 72.88M$.

Who is the top mutual fund holder of Foghorn Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Foghorn Therapeutics shares, with 4.76% of its total shares outstanding invested in 2.63M Foghorn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools